Falcon Point Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Falcon Point Capital’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-36,543	Closed	-$70K	–	95
2020 Q1	$70K	Sell	36,543 -5,664	-13%	-$14.9K	0.15%	93
2019 Q4	$120K	Hold	42,207	–	–	0.15%	105
2019 Q3	$130K	Buy	42,207 +1,458	+4%	+$4.62K	0.07%	102
2019 Q2	$132K	Sell	40,749 -24,250	-37%	-$86.3K	0.07%	102
2019 Q1	$243K	Buy	64,999 +1,390	+2%	+$4.86K	0.13%	87
2018 Q4	$219K	Sell	63,609 -13,151	-17%	-$64.9K	0.13%	88
2018 Q3	$550K	Sell	76,760 -5,564	-7%	-$43.2K	0.12%	75
2018 Q2	$575K	Buy	82,324 +15,857	+24%	+$98.6K	0.11%	93
2018 Q1	$416K	Buy	66,467 +241	+0.4%	+$1.52K	0.08%	97
2017 Q4	$371K	Sell	66,226 -53,083	-44%	-$242K	0.06%	98
2017 Q3	$492K	Buy	+119,309	New	+$630K	0.07%	97

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Falcon Point Capital's APEN Position: Q2 2020 in Review

Falcon Point Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2020, closing a stake of 36,543 shares — an estimated $70K sold.

Falcon Point Capital first reported a position in APEN in Q3 2017 and held it in 11 quarters. The position peaked at $575K in Q2 2018. 32 funds tracked by Wall St. Rank hold APEN as of Q2 2020.

Falcon Point Capital reported no remaining Apollo Endosurgery, Inc. position as of Q2 2020 after selling out during the quarter.
Falcon Point Capital sold 36,543 Apollo Endosurgery, Inc. shares in Q2 2020, an estimated $70K.
Falcon Point Capital first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 11 quarters.
Falcon Point Capital's Apollo Endosurgery, Inc. position peaked at $575K in Q2 2018.
32 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2020.

Based on Falcon Point Capital's 13F filing for Q2 2020, filed 21 Jul 2020.